Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia
Serrano C.V. Jr., Yoshida V.M., Venturinelli M.L., et al. Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia. Atherosclerosis. 157:2001;505-512.
HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia
Weber C., Erl W., Weber K.S.C., Weber P.C. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J. Am. Coll. Cardiol. 30:1997;1212-1217.
Oxidized lipoprotein(a) induces cell adhesion molecule MAC-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells
Ragab M.S., Selvaraj P., Sgoutas D.S. Oxidized lipoprotein(a) induces cell adhesion molecule MAC-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. Atherosclerosis. 123:1996;103-113.
In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils a monocytes with relevance for the in vivo situation
Lehr H.A., Krombach F., Munzing S., et al. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils a monocytes with relevance for the in vivo situation. Am. J. Pathol. 146:1995;218-227.
Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: Further evidence for smoldering inflammation in patients with atherosclerosis
Kassirer M., Zeltser D., Prochorov V., et al. Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: further evidence for smoldering inflammation in patients with atherosclerosis. Am. Heart J. 138:1999;555-559.
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
Ridker P.M., Rifai N., Pfeffer M.A., et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 98:1998;839-844.